Metabolic Bone Diseases and New Drug Developments-Reference-Cited by-同舟云学术

Metabolic Bone Diseases and New Drug Developments

Published:2022-03-28 Issue:4 Volume:30 Page:309-319
ISSN:1976-9148
Container-title:Biomolecules & Therapeutics
language:en
Short-container-title:Biomol Ther (Seoul)

Author:

Natesan Vijayakumar¹,Kim Sung-Jin²

Affiliation:

1. Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar 608002, Tamil Nadu, India

2. Department of Pharmacology and Toxicology, Metabolic Diseases Research Laboratory, School of Dentistry, Kyung Hee University, Seoul 02447, Republic of Korea

Publisher

The Korean Society of Applied Pharmacology

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Biochemistry

Link

http://pdf.medrang.co.kr/BT2/2022/030/BT030-04-309.pdf

Reference105 articles.

1. Esophageal and gastric cancer incidence and mortality in alendronate users

2. Bone Health and the Female Athlete Triad in Adolescent Athletes

3. Factors influencing the relationship between fluoride in drinking water and dental fluorosis: a ten-year systematic review and meta-analysis

4. Hypoparathyroidism

5. IoT-based telemedicine for disease prevention and health promotion: State-of-the-Art

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sensing the future: A review on emerging technologies for assessing and monitoring bone health;Biomaterials Advances;2024-12

2. 3D Printing of Polysaccharide-Based Hydrogel Scaffolds for Tissue Engineering Applications: A Review;International Journal of Biological Macromolecules;2024-06

3. Systematical mutational analysis of teriparatide on anti-osteoporosis activity by alanine scanning;Bioorganic & Medicinal Chemistry Letters;2024-05

4. The Safety and Efficacy of Abaloparatide on Postmenopausal Osteoporosis: A Systematic Review and Meta-analysis;Clinical Therapeutics;2024-03

5. 2,4′-Dihydroxybenzophenone Exerts Bone Formation and Antiosteoporotic Activity by Stimulating the β-Catenin Signaling Pathway;ACS Pharmacology & Translational Science;2024-01-19